• 1
    Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93: 82442.
  • 2
    Cancer Facts & Figures 2002. American Cancer Society, Inc. SEER Cancer Statistics Review, 1973–1998.
  • 3
    Blatt J, Copeland DR, Bleyer A. Late effects of childhood cancer and its treatment. In: PizzoPA, PoplackDG, editors. Principles and practice of pediatric oncology, 2nd ed. Philadelphia: JB Lippincott, 1993. 1091114.
  • 4
    Hawkins MM, Stevens MC. The long-term survivors. Br Med Bull 1996; 52: 898923.
  • 5
    Meadows AT, Hobbie WL. The medical consequences of cure. Cancer 1986; 15 (suppl 2): 5248.
  • 6
    Ried H, Zietz H, Jaffe N. Late effects of cancer treatment in children. Pediatr Dent 1995; 17: 27384.
  • 7
    Marina N. Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am 1997; 44: 102142.
  • 8
    Stevens MC, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998; 34: 6948.
  • 9
    Loescher LJ, Welch-McCaffrey D, Leigh SA, Hoffman B, Meyskens FL. Surviving adult cancers. Part 1: Physiologic effects. Ann Intern Med 1989; 111: 41132.
  • 10
    Ganz PA. Late effects of cancer and its treatment. Semin Oncol Nurs 2001; 17: 2418.
  • 11
    Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, Strong EW, Rao A, Thaler H, Polyak T, Portenoy R. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997; 16975.
  • 12
    Loescher LJ, Clark L, Atwood JR, Leigh S, Lamb G. The impact of the cancer experience on long-term survivors. Oncol Nurs Forum 1990; 17: 2239.
  • 13
    Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the prostate cancer outcomes study. J Clin Oncol 2001; 19: 251726.
  • 14
    Rudberg L, Carlsson M, Nilsson S, Wikblad K. Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nurs 2002; 25: 18795.
  • 15
    Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 2002; 20: 29209.
  • 16
    Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology 2002; 11: 14253.
  • 17
    Abrahamsen AF, Loge JH, Hannisdal E, Holte H, Kvaloy S. Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution. Eur J Cancer 1998; 34: 186570.
  • 18
    Armitage JO. Long-term toxicity of the treatment of Hodgkin's disease. Ann Oncol 1998; 9 (suppl 5): S1336.
  • 19
    Greil R, Holzner B, Kemmler G, Kopp M, Buchowski A, Oberaigner W, Fritsch E, Dirnhofer S, Rueffer U, Diehl V, Sperner-Unterweger B. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999; 35: 698706.
  • 20
    Hohl RJ, Schilsky RL. Nonmalignant complications of therapy for Hodgkin's disease. Hematol Oncol Clin North Am 1989; 3: 33143.
  • 21
    Blackwell DL, Collins JG, Coles R. Summary health statistics for U.S. adults: National Health Interview Survey, 1997. National Center for Health Statistics. Vital Health Stat 2002; 10.
  • 22
    Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA. Making effective use of tumor registries for cancer survivorship research. Cancer 2001; 92: 130514.
  • 23
    Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999; 91: 14806.
  • 24
    Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer (English language edition) 1998; 7: 18191.
  • 25
    Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol 1999; 10: 717.
  • 26
    Armitage JO. Long-term toxicity of the treatment of Hodgkin's disease. Ann Oncol 1998; 9: s1336.
  • 27
    Abrahamsen AF, Loge JH, Hannisdal E, Holte H, Kvaloy S. Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution. Eur J Cancer 1998; 34: 186570.
  • 28
    Schwartz CL. Late effects of treatment in long-term survivors of cancer. Cancer Treat Rev 1995; 21: 35566.
  • 29
    Leandro J, Dyck J, Poppe D, Shore R, Airhart C, Greenberg M, Gilday D, Smallhorn JF, Benson L. Cardiac dysfunction late after cardiotoxic therapy for childhood cancer. Am J Cardiol 1994; 74: 11526.
  • 30
    Rutqvist LE, Liedberg A, Hammar N, Dalberg K. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation. Int J Radiat Oncol Biol Phys 1998; 40: 35963.
  • 31
    Meinardi MT, Gietema JA, van der Graaf WTA, van Veldhuisen DJ, Runne MA, Sluiter WJ, de Vries EGE, Willemse PBH, Mulder NH, van den Berg MP, Schraffordt H, Sleijfer DT. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000; 18: 172532.
  • 32
    Theuws JCM, Muller SH, Seppenwoolde Y, Kwa SLS, Boersma LJ, Hart GAM, Baas P, LeBesque J. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: a follow-up study. J Clin Oncol 1999; 17: 3091100.
  • 33
    Dorresteijn LDA, Kappelle AC, Boogerd W, Klokman WJ, Balm AJM, Keus RB, van Leeuwen FE, Bartelink H. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002; 20: 2828.
  • 34
    Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 2000; 18: 157093.
  • 35
    Gagel RF, Vassilopoulou-Sellin R. Preventing bone loss and fractures. Coping 1998; 12: 689.
  • 36
    Averette HE, Boike GM, Jarrell MA. Effects of cancer chemotherapy on gonadal function and reproductive capacity. CA Cancer J Clin 1990; 40: 199209.
  • 37
    Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Adverse effects of treatment: gonadal dysfunction. In: DeVitaVTJr, HellmasS, RosenbergSA, editors. Cancer: principles and practice of oncology, 6th ed. Philadelphia: JB Lippincott; 2001. 292339.
  • 38
    Hollen PJ, Hobbie WL. Establishing comprehensive specialty follow-up clinics for long-term survivors of cancer. Providing systematic physiological and psychosocial support. Support Care Cancer 1995; 3: 402.